2023•Obstetric Anesthesia DigestRequires access

Buprenorphine Versus Methadone for Opioid Use Disorder in Pregnancy

Elizabeth A. Suarez, Krista F. Huybrechts, Loreen Straub, Brian T. Bateman

Abstract

(N Engl J Med. 2022;387:2033–2044) Opioid use during pregnancy has been on the rise since 2000. The standard care for opioid use disorder during pregnancy is either buprenorphine or methadone treatment, which both have been shown to improve maternal and neonatal outcomes. Buprenorphine may have greater benefits, yet data is limited. This study aimed to analyze the risk of adverse outcomes for mother and baby with buprenorphine treatment compared to methadone treatment for opioid use during pregnancy.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Buprenorphine, Methadone, Medicine, Opioid use disorder, Pregnancy, Opiate Substitution Treatment, Opioid, Anesthesia